Addition of montelukast versus double dose of inhaled budesonide in moderate persistent asthma


YILDIRIM Z., Ozlu T. , BULBUL Y. , BAYRAM H.

RESPIROLOGY, cilt.9, ss.243-248, 2004 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background: Although current guidelines suggest the use of inhaled corticosteroids as the first line therapy in persistent asthma, the concerns about high-dose corticosteroids may limit their usage. We aimed to investigate the efficacy of inhaled budesonide plus oral montelukast versus a double dose of inhaled budesonide.